This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
, No Gclids
Disease Info Card
Systemic Onset Juvenile Chronic Arthritis
Information about Systemic Onset Juvenile Chronic Arthritis: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.
Overview of Systemic Onset Juvenile Chronic Arthritis
Most recent studies have shown that Systemic Onset Juvenile Chronic Arthritis shares some biological mechanisms with adult-onset-still-disease, arthritis, arthritis-juvenile-rheumatoid, autoimmune-diseases, autoimmune-reaction, chronic-arthritis, exanthema, histiocytosis-haematophagic, infective-disorder, inflammation, inflammatory-disorder, juvenile-onset-still-disease, lupus-erythematosus-systemic, lymphohistiocytosis-hemophagocytic, macrophage-activation-syndrome, polyarthritis, rheumatism, rheumatoid-arthritis.
Among the many pathways, these few ones have gauged particular interests from scientists studying Systemic Onset Juvenile Chronic Arthritis, and have been seen in publications frequently: Cell Cycle, Cell Death, Cell Differentiation, Coagulation, Cytokine Production, Cytolysis, Endochondral Ossification, Fibrinolysis, Glycosylation, Immune Response, Inflammatory Response, Macrophage Activation, Macrophage Differentiation, Oncogenesis, Ossification, Pathogenesis, Phagocytosis, Photoprotection, Proteolysis, Secretory Pathway
Quite a number of genes have been found to play important roles in Systemic Onset Juvenile Chronic Arthritis, such as ACR, CD163, COMP, CRP, CTLA4, ESR1, HLA-DQA1, IL10, IL18, IL1B, IL1RN, IL6, IL6ST, MAS1, NLRP3, NOD2, S100A8, TNF. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.
In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.